Proteomic insights uncover enhanced neurotherapeutic potential in conditioned mesenchymal stem cell-derived extracellular vesicles

Abstract

Extracellular vesicles (EVs) show more potential as therapeutic agents for treating neurological disorders than their parent cells like MSCs. Notably, the therapeutic efficacy of MSCs can be boosted by inflammation factors and oxidative stressors. Here, we investigated the impact of activated microglial cell supernatant (Con1) and hydrogen peroxide (Con2) on MSCs and collected their derived EVs, followed by using high-resolution mass spectrometry to analyze MSC-EV proteomic and phosphoproteomic profiles, and verified the indicated functional protein and phosphorylated kinase as well. Our findings showed that both Con1 and Con2 EVs exhibited characteristic features of extracellular vesicles and possessed greater anti-inflammatory and antioxidant activity compared to unconditioned MSC-EVs. Omics analysis revealed alterations in protein expression and phosphorylation associated with inflammation and oxidation biological processes and signaling pathways, as well as signified the post-translational modification of proteins in Con1/2 EVs. Importantly, we identified that the anti-inflammatory role of MSC-EVs was linked to the serine/threonine kinase phosphorylation, and inhibition of insulin-like growth factor 1 receptor (IGF1R) reduced the antioxidant activity of MSC-EVs. This report documented the changed protein expression and phosphorylated patterns of Con1/2 EVs, and provided insights into the functionalization mode of MSC-EVs, suggesting the enhanced neurotherapeutic potential of conditioned EVs in the treatment of neurological diseases.

Keywords

• Extracellular vesicles
• Conditioned stimulus
• Neurotherapeutic
• Proteomics
• Phosphoproteomics